Literature DB >> 22496109

Endovascular correction of cerebrovenous anomalies in multiple sclerosis: a retrospective review of an uncontrolled case series.

Michael D Dake1, Nicholas Dantzker, William L Bennett, John P Cooke.   

Abstract

Endovascular intervention for obstruction to venous drainage of the head and neck is an established treatment for disorders such as superior vena cava syndrome. Some patients with multiple sclerosis have been observed to have anomalies of the veins draining the head and neck. It is possible that some symptoms associated with multiple sclerosis may be secondary to disturbed venous flow. In an uncontrolled clinical series of 40 patients who had been previously diagnosed with multiple sclerosis, anomalies of the venous drainage of the head and neck were observed, including venous stenoses of the internal jugular veins. In 38 of 40 patients, venous stents were placed with restoration of luminal dimensions and abrogation of the venous pressure gradient. The angiographic and hemodynamic improvement was associated with improvement in symptomatology, most particularly in cognitive and constitutional symptoms that may be related to cerebrovenous flow. Serious complications included death in one subject and stent embolization requiring open heart surgery in another. In conclusion, in this series, endovascular intervention to correct venous stenosis associated with multiple sclerosis was associated with improvement in symptoms possibly related to disturbed venous hemodynamics. However, given the serious adverse events in this small series, a randomized clinical trial is required to confirm these findings, and to determine if the procedure has any effect on the progression of multiple sclerosis, or untoward long-term adverse effects.

Entities:  

Mesh:

Year:  2012        PMID: 22496109      PMCID: PMC4164629          DOI: 10.1177/1358863X12440125

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  26 in total

1.  Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity.

Authors:  Yulin Ge; Meng Law; Glyn Johnson; Joseph Herbert; James S Babb; Lois J Mannon; Robert I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

Review 2.  Molecular mechanisms in chronic venous insufficiency.

Authors:  John Bergan
Journal:  Ann Vasc Surg       Date:  2007-05       Impact factor: 1.466

Review 3.  Blood-brain barrier imaging and therapeutic potentials.

Authors:  Fidel Rebeles; James Fink; Yoshimi Anzai; Kenneth R Maravilla
Journal:  Top Magn Reson Imaging       Date:  2006-04

4.  Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis.

Authors:  Matilde Inglese; Sumita Adhya; Glyn Johnson; James S Babb; Laura Miles; Hina Jaggi; Joseph Herbert; Robert I Grossman
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-02       Impact factor: 6.200

5.  Spontaneous intracerebral hemorrhage in a patient with multiple sclerosis and tumefactive demyelinating lesion.

Authors:  O Stich; D Janowitz; S Rauer
Journal:  Mult Scler       Date:  2009-03-12       Impact factor: 6.312

6.  Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.

Authors:  May H Han; Sun-Il Hwang; Dolly B Roy; Deborah H Lundgren; Jordan V Price; Shalina S Ousman; Guy Haskin Fernald; Bruce Gerlitz; William H Robinson; Sergio E Baranzini; Brian W Grinnell; Cedric S Raine; Raymond A Sobel; David K Han; Lawrence Steinman
Journal:  Nature       Date:  2008-02-17       Impact factor: 49.962

Review 7.  Historical and clinical perspectives of the expanded disability status scale.

Authors:  John F Kurtzke
Journal:  Neuroepidemiology       Date:  2008-06-06       Impact factor: 3.282

8.  Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging.

Authors:  E Mark Haacke; Malek Makki; Yulin Ge; Megha Maheshwari; Vivek Sehgal; Jiani Hu; Madeswaran Selvan; Zhen Wu; Zahid Latif; Yang Xuan; Omar Khan; James Garbern; Robert I Grossman
Journal:  J Magn Reson Imaging       Date:  2009-03       Impact factor: 4.813

Review 9.  The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis.

Authors:  Paolo Zamboni
Journal:  J R Soc Med       Date:  2006-11       Impact factor: 18.000

10.  Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.

Authors:  P Zamboni; R Galeotti; E Menegatti; A M Malagoni; G Tacconi; S Dall'Ara; I Bartolomei; F Salvi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-12-05       Impact factor: 10.154

View more
  3 in total

1.  Chronic Cerebro-Spinal Venous Insufficiency in Multiple Sclerosis: Is It the End?

Authors:  Alessandro Rasman
Journal:  Vasc Specialist Int       Date:  2018-03-31

2.  Safety and efficacy of venoplasty in MS: A randomized, double-blind, sham-controlled phase II trial.

Authors:  Anthony L Traboulsee; Lindsay Machan; J Marc Girard; Jean Raymond; Reza Vosoughi; Brian W Hardy; Francois Emond; Jean-Luc Gariepy; Jeffrey N Bone; Gary Siskin; Darren Klass; Saul Isserow; Judy Illes; A Dessa Sadovnick; David K Li
Journal:  Neurology       Date:  2018-09-28       Impact factor: 9.910

3.  Cortical morphology predicts placebo response in multiple sclerosis.

Authors:  Mariya V Cherkasova; Jessie F Fu; Michael Jarrett; Poljanka Johnson; Shawna Abel; Roger Tam; Alexander Rauscher; Vesna Sossi; Shannon Kolind; David K B Li; A Dessa Sadovnick; Lindsay Machan; J Marc Girard; Francois Emond; Reza Vosoughi; Anthony Traboulsee; A Jon Stoessl
Journal:  Sci Rep       Date:  2022-01-14       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.